|
|
|
|
|
|
| | |
|
Press Release
DCAT Welcomes Four New Member Companies
Robbinsville, NJ, November 30, 2010 – The Drug, Chemical and Associated Technology Association (DCAT), the pharmachem industry’s premier business development association, is pleased to announce the addition of Budenheim USA, Inc., Dolder AG, Fresenius Kabi Oncology Limited and Human Genome Sciences, Inc. as new member companies. To learn about other DCAT member companies, visit DCAT’s Meet Our Members.
Budenheim USA
Budenheim USA Inc. is a subsidiary of Budenheim, producers of specialty phosphates, servicing a wide variety of end-use markets including nutrition, pharmaceutical, industrial, baking, dairy, meat, processed foods and seafood. www.budenheim.com
Dolder AG
Established in 1898, Dolder Fine Chemicals is the reliable expert for active pharmaceutical ingredients (API). We are the sourcing experts with clearly defined time lines, Swiss quality, fair prices and a successful track record that we are proud of. We are active worldwide with a focus on selected markets in Europe, Asia, and America. www.dolder.com
Fresenius Kabi Oncology Limited
Fresenius Kabi Oncology Limited specializes in the field of oncology supported by integrated manufacturing, regulatory, sales, marketing and distribution set up. The company has world-class expertise for development and manufacturing of finished products and APIs. Regulatory authorities like USFDA, EDQM & TGA have endorsed its commitment to Quality by Design. www.fresenius-kabi-oncology.com
Human Genome Sciences, Inc.
The mission of Human Genome Sciences is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs. www.hgsi.com
About DCAT
DCAT is the premier business development association whose membership is comprised of companies that manufacture, distribute or provide services to the pharmaceutical, chemical and related industries.
Contact:
Erin Sanders
DCAT Communications Coordinator
609-448-1000
|
| |
| | |
|
|
|